The primary purpose is to continue and advance the review program developed and implemented by the Quality Assurance Review Center (QARC). Well over 2000 patients per year can be expeditiously and effectively monitored on over 40 protocols at any one time by the current staff at the QARC with the equipment available and with the improved data base management system that is being implemented. Electronic communication may make possible the management of an even larger number of cases and a more effective review process may emerge. Since QARC was established in 1980 to perform quality assurance for radiotherapy components in cooperative group trials, over 8000 patients on 78 protocols in 6 cooperative groups have been processed. Data submission and the appropriateness of the treatment both improves substantially in all groups monitored by QARC. The QARC has also been involved in protocol development to assist in making protocols as umambiguous as possible. The QARC staff has developed educational workshops for each of the groups to enhance the protocol participation. it is our purpose to continue to serve the cooperative groups and to explore improved methods of data handling for the most effective and efficient data management by transferring our data base management to a VAX 750. A pilot study of electronic communication is being developed which will allow the participating institution to be linked by a """"""""star"""""""" network to the QARC computer. This will allow us to expedite routine communications, protocol development, data requests and data acquisition including digital data, graphics and radiological images. The large data base which QARC has accumulated over the last 5 years can be used to develop mathematical models of changes in protocol participation which can describe protocol performance and learning time as functions of protocol complexity, type of institution participating in the protocol and the experience of the radiotherapist. These mathematical models may be used to selectively modify the review process and for educational programs targeted differentially to different classes of protocols, institutions or participants.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Cooperative Clinical Research--Cooperative Agreements (U10)
Project #
5U10CA029511-08
Application #
3557083
Study Section
Cancer Clinical Investigation Review Committee (CCI)
Project Start
1981-01-01
Project End
1990-12-31
Budget Start
1988-01-01
Budget End
1988-12-31
Support Year
8
Fiscal Year
1988
Total Cost
Indirect Cost
Name
Rhode Island Hospital (Providence, RI)
Department
Type
DUNS #
161202122
City
Providence
State
RI
Country
United States
Zip Code
02903
FitzGerald, Thomas J; Bishop-Jodoin, Maryann (2018) Hodgkin Lymphoma: Differences in Treatment Between Europe and the United States/North America: Evolving Trends in Protocol Therapy. Clin Med Insights Oncol 12:1179554918754885
Katzenstein, Howard M; Furman, Wayne L; Malogolowkin, Marcio H et al. (2017) Upfront window vincristine/irinotecan treatment of high-risk hepatoblastoma: A report from the Children's Oncology Group AHEP0731 study committee. Cancer 123:2360-2367
Garg, Madhur K; Zhao, Fengmin; Sparano, Joseph A et al. (2017) Cetuximab Plus Chemoradiotherapy in Immunocompetent Patients With Anal Carcinoma: A Phase II Eastern Cooperative Oncology Group-American College of Radiology Imaging Network Cancer Research Group Trial (E3205). J Clin Oncol 35:718-726
Sparano, Joseph A; Lee, Jeannette Y; Palefsky, Joel et al. (2017) Cetuximab Plus Chemoradiotherapy for HIV-Associated Anal Carcinoma: A Phase II AIDS Malignancy Consortium Trial. J Clin Oncol 35:727-733
O'Neill, Allison F; Towbin, Alexander J; Krailo, Mark D et al. (2017) Characterization of Pulmonary Metastases in Children With Hepatoblastoma Treated on Children's Oncology Group Protocol AHEP0731 (The Treatment of Children With All Stages of Hepatoblastoma): A Report From the Children's Oncology Group. J Clin Oncol 35:3465-3473
Wozniak, Antoinette J; Moon, James; Thomas Jr, Charles R et al. (2015) A Pilot Trial of Cisplatin/Etoposide/Radiotherapy Followed by Consolidation Docetaxel and the Combination of Bevacizumab (NSC-704865) in Patients With Inoperable Locally Advanced Stage III Non-Small-Cell Lung Cancer: SWOG S0533. Clin Lung Cancer 16:340-7
Trippett, Tanya M; Schwartz, Cindy L; Guillerman, R Paul et al. (2015) Ifosfamide and vinorelbine is an effective reinduction regimen in children with refractory/relapsed Hodgkin lymphoma, AHOD00P1: a children's oncology group report. Pediatr Blood Cancer 62:60-4
Dharmarajan, Kavita V; Friedman, Debra L; Schwartz, Cindy L et al. (2015) Patterns of relapse from a phase 3 Study of response-based therapy for intermediate-risk Hodgkin lymphoma (AHOD0031): a report from the Children's Oncology Group. Int J Radiat Oncol Biol Phys 92:60-6
Dharmarajan, Kavita V; Friedman, Debra L; FitzGerald, T J et al. (2015) Radiotherapy quality assurance report from children's oncology group AHOD0031. Int J Radiat Oncol Biol Phys 91:1065-71
Servaes, Sabah; Khanna, Geetika; Naranjo, Arlene et al. (2015) Comparison of diagnostic performance of CT and MRI for abdominal staging of pediatric renal tumors: a report from the Children's Oncology Group. Pediatr Radiol 45:166-72

Showing the most recent 10 out of 60 publications